Core Viewpoint - The company has decided not to pursue the renewal of the mining license for the Dejiang mine due to financial constraints and regulatory uncertainties, focusing instead on the operations of the Yongfeng mine, which holds a valid mining license and has potential for capacity expansion [1][2][3] Group 1: Mining License Renewal - The renewal application for the mining license was accepted in 2019, but the authorities rejected it on December 29, 2024, leading the company to resubmit the application [1] - The company has not received any positive feedback regarding the renewed application, and the board has decided against investing additional resources into the renewal process due to financial and regulatory uncertainties [1][2] - The renewal process requires significant financial and management resources, which the board deems not in the best commercial interest of the company [1][2] Group 2: Financial Strategy - Given the current financial situation, the company has opted for a more prudent allocation of financial resources, prioritizing cash for operations and loan repayments [2] - The board believes that focusing on the Yongfeng mine, which has a valid mining license and room for capacity expansion, will yield better returns for the company [2] - The tightening industry standards and increasing regulatory enforcement create significant uncertainty regarding the acceptance of the renewal application and the associated costs [2] Group 3: Operational Impact - The Dejiang mine has not generated any revenue in recent years, and its mining rights have been fully impaired as of 2024 [3] - The decision not to pursue the renewal of the mining license is not expected to have a significant adverse impact on the overall business and financial condition of the company [3] - The marble products division will continue normal operations and remain a primary source of revenue, with the board committed to allocating resources to this segment and exploring new business opportunities [3]

Core Viewpoint - The company has decided not to pursue the renewal of the mining license for the Dejiang mine due to financial constraints and regulatory uncertainties, focusing instead on the operations of the Yongfeng mine, which has a valid mining license and potential for capacity expansion [1][2]. Group 1: Mining License Renewal - The renewal application for the mining license was accepted in 2019, but the authorities rejected it on December 29, 2024, leading the company to resubmit the application [1]. - The company has not received any positive feedback regarding the renewed application, and the board has decided against investing additional resources into the renewal process due to financial and regulatory uncertainties [1][2]. - The renewal process requires significant financial and management resources, which the company deems not in its best commercial interest given the current market conditions [2]. Group 2: Financial Strategy - The company is prioritizing cash for current operations and loan repayments, opting for a more prudent use of financial resources [2]. - The board believes that focusing on the Yongfeng mine, which has an effective mining license and room for capacity expansion, will yield better returns for the company [2]. - The tightening industry standards and increasing regulatory enforcement create significant uncertainty regarding the approval of the renewal application and the associated costs [2]. Group 3: Market Conditions - The marble products industry in China has faced challenges due to a slowdown in the commercial and residential property markets, leading to reduced demand and pressure on sales prices and profit margins [2]. - The Dejiang mine has not generated any revenue in recent years, and its mining rights have been fully impaired as of 2024, indicating that the decision not to pursue the license renewal will not significantly impact the company's overall business and financial status [3]. - The marble products division will continue to operate normally and remain a primary source of revenue, with the board committed to allocating resources to this segment and exploring new business opportunities [3].

Core Viewpoint - Des Holdings (08437.HK) has entered into a sale agreement to sell its wholly-owned subsidiary, Des (Hong Kong) Holdings, for a consideration of HKD 1, which will result in the subsidiary no longer being consolidated into the group's financial statements [1] Group 1: Transaction Details - The sale agreement is between the company (as the seller) and buyer Yan Xianchang, with the transaction set to complete by December 31, 2025 [1] - Following the completion of the sale, the company will no longer hold any issued share capital of the target company [1] Group 2: Financial Impact - The board believes that the sale will not have any significant adverse impact on the overall financial condition and operations of the group [1] - The transaction is expected to reduce liabilities and lower the debt-to-asset ratio, thereby improving the financial position of the group [1] - The sale will streamline business operations and allow for the reallocation of existing resources to focus on core business development [1] Group 3: Fairness of Terms - The board considers the terms of the sale to be normal commercial terms, fair, reasonable, and in the overall interest of the company and its shareholders [1]

智通财经APP讯，中建富通(00138)发布公告，于2025年12月31日，该等卖方(East Advance Holdings Limited(作为卖方A)及 Blackbird Automotive Holding Limited(作为卖方B)各为公司全资附属公司)与买方 Entex International Holding Limited 订立买卖协议。 据此，该等卖方同意出售而买方同意购买待售股份(占目标公司 Blackbird Works Supply Co. Limited 95% 已发行股本)，代价为1710万港元。买卖协议为无条件及完成已于2025年12月31日落实。 紧接出售事项前，目标公司分别由卖方A拥有99.999%及由卖方B拥有0.001%。目标公司主要于香港提 供汽车拖运及物流服务。完成后，目标公司由买方拥有95%及由卖方A拥有5%。 董事认为，出售事项对集团有利，乃由于其能简化集团的组织结构及精简业务运营;改善集团的营运资 金状况;及免除目标公司未来业务发展所需的额外现金流注资要求。 ...

面对业绩下行与股东压力，百事公司已与激进投资机构埃利奥特（Elliott Investment Management）达成战略改革协议，旨在通过业务精简、成本 重组与产品线聚焦应对当前增长困境。 根据12月9日公布的方案，百事将在2026年前实施以下结构性调整：削减美国市场近20%的产品线（SKU）、关闭三家工厂并推动裁员与产线优 化、将资源转向平价产品与健康化创新。该计划直接回应了埃利奥特此前对其"品牌臃肿、市场份额流失"的批评。 此次合作源于埃利奥特于2024年建立的约40亿美元百事股份持仓。在百事股价较2023年高点下跌约25%、同时面临碳酸饮料与零食双线竞争压力 的背景下，该协议被视为管理层主动推进改革、以规避潜在代理权争夺的防御性举措。公司同步更新业绩指引，预计2026财年有机收入增长 2%-4%，并通过供应链与运营优化，目标在三年内推动核心营业利润率提升至少100个基点。 根据协议，百事公司将围绕产品、成本与营销展开系统性改革。产品端将实施"平价化"与"健康化"双轨策略：一方面扩大全渠道低价日常产品供 给，另一方面计划于2026年推出以高蛋白、全谷物、零添加为特点的"清洁标签"创新系列，包括Sim ...

Core Viewpoint -耀星科技集团 plans to sell its entire issued share capital of Anxu Technology Co., Ltd. to Syno Strategy Ltd for a total consideration of HKD 110 million, aiming to streamline operations and focus on its core visual display solutions business [1] Group 1: Company Strategy - The sale is part of a strategic decision to terminate non-core businesses in China, specifically in IT consulting and hotel booking and event planning services [1] - The board believes that this move will help reduce losses and reallocate management and financial resources to strengthen and expand the core business [1] Group 2: Financial Details - The total consideration for the sale is HKD 110 million [1]

Core Viewpoint - The company,耀星科技集团, plans to sell its entire issued share capital of 安绪科技有限公司 to Syno Strategy Ltd for a total consideration of HKD 110 million, aiming to streamline operations and focus on its core visual display solutions business [1] Group 1: Business Strategy - The sale is part of a strategic decision to terminate non-core businesses in China, specifically in IT consulting and hotel booking and event planning services [1] - The board believes that this move will help reduce losses and reallocate management and financial resources to strengthen and expand the core business [1]

Group 1 - Fosun Pharmaceutical (001288) announced the sale of its wholly-owned subsidiary, Henan Fosun Smart Energy Technology Co., Ltd., for 73 million yuan to Henan Xisheng Industrial Development Co., Ltd. [1] - The buyer, Henan Xisheng, is jointly controlled by Nanyang Industrial Investment Group (51% stake) and the Xichuan Finance Bureau (49% stake), focusing on property leasing, equipment leasing, and overseas engineering contracting [3]. - The subsidiary, Fosun Smart Energy, primarily operates photovoltaic power generation systems, with three installed capacities of approximately 6.09 MW, 6.38 MW, and 14.89 MW [3]. Group 2 - Fosun Pharmaceutical stated that its core business is pharmaceutical manufacturing and sales, and the photovoltaic business was initially intended to support internal power needs and generate external revenue, but it is not a core focus of the group [3]. - The sale aligns with the company's long-term strategy to streamline operations and focus on key business areas, and it will not significantly impact the company's daily pharmaceutical production and operations [3].

Core Viewpoint - The company is engaging in significant asset sales to improve liquidity and focus on core business operations, which is expected to enhance financial stability and operational efficiency [1][2][3] Group 1: Asset Sales - The company announced the conditional sale of an 18.06% stake in its joint venture, Science City Financing Leasing, for RMB 417 million [1] - Additionally, the company plans to sell all shares of Hengcheng for RMB 11.3386 million, with the completion of this sale contingent upon Hengcheng undergoing a restructuring process [1][2] Group 2: Financial Impact - The restructuring of Hengcheng will involve transferring non-core assets and liabilities, resulting in a net restructuring obligation of approximately RMB 122 million as of June 30, 2025 [2] - The company reported a current liability exceeding current assets by approximately RMB 699 million as of December 31, 2024, with cash and cash equivalents around RMB 20 million [3] - Proceeds from the asset sales are expected to be used to repay shareholder loans, improving the company's net debt situation and reducing interest payments, thereby enhancing profitability [3] Group 3: Strategic Focus - The asset sales are part of a strategy to streamline operations and optimize resource allocation, allowing the company to concentrate on its core business [2] - The board believes that focusing resources on core operations will improve profitability and strengthen the long-term outlook of the business [3]

Core Viewpoint - The company is engaging in significant asset sales to improve liquidity and focus on core business operations, which is expected to enhance financial stability and operational efficiency [1][2][3] Group 1: Asset Sales - The company has agreed to sell an 18.06% stake in its joint venture, Science City Financing Leasing, for RMB 417 million [1] - Additionally, the company will sell all shares of Heng Cheng for RMB 11.34 million, with Heng Cheng undergoing a restructuring process prior to the sale [1][2] Group 2: Financial Impact - The restructuring of Heng Cheng will involve transferring non-core assets and liabilities, resulting in a net restructuring obligation of approximately RMB 122 million as of June 30, 2025 [2] - The company reported a current liability exceeding current assets by approximately RMB 699 million as of December 31, 2024, with cash and cash equivalents around RMB 20 million [3] - Proceeds from the asset sales will be used to repay shareholder loans, improving the company's net debt situation and reducing interest payments, thereby enhancing profitability [3] Group 3: Strategic Focus - The asset sales are part of a strategy to streamline operations and optimize resource allocation, allowing the company to concentrate on its core business [2][3] - The board believes that focusing on core operations will improve profitability and strengthen the long-term outlook of the business [3]